Skip to main content
OpenTrials

Clinical trial condition

Refractory AL Amyloidosis

Explore clinical trials studying Refractory AL Amyloidosis. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Refractory AL Amyloidosis trial results

Active, Not Recruiting

Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis

NCT04847453

Conditions
Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +11 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab

NCT04270175

Conditions
AL Amyloidosis, Alzheimer Disease, Amyloid, +21 more
Locations
  • Stanford University Palo Alto, California, United States
  • Boston University Medical Center Boston, Massachusetts, United States
  • Weill Cornell Medicine - Multiple Myeloma Center New York, United States
  • Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details

Related conditions